These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 15191645

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Transcriptional-based screens for pathway-specific, high-throughput target discovery in endothelial cells.
    Yauch RL, Kadel EE, Nicholas C, Tetangco S, Clary DO.
    J Biomol Screen; 2004 Dec; 9(8):704-11. PubMed ID: 15634797
    [Abstract] [Full Text] [Related]

  • 23. Virus-based expression systems facilitate rapid target in vivo functionality validation and high-throughput screening.
    Darrow AL, Conway KA, Vaidya AH, Rosenthal D, Wildey MJ, Minor L, Itkin Z, Kong Y, Piesvaux J, Qi J, Mercken M, Andrade-Gordon P, Plata-Salamán C, Ilyin SE.
    J Biomol Screen; 2003 Feb; 8(1):65-71. PubMed ID: 12854999
    [Abstract] [Full Text] [Related]

  • 24. Optimization procedure for small interfering RNA transfection in a 384-well format.
    Borawski J, Lindeman A, Buxton F, Labow M, Gaither LA.
    J Biomol Screen; 2007 Jun; 12(4):546-59. PubMed ID: 17435168
    [Abstract] [Full Text] [Related]

  • 25. Learning from the data: mining of large high-throughput screening databases.
    Yan SF, King FJ, He Y, Caldwell JS, Zhou Y.
    J Chem Inf Model; 2006 Jun; 46(6):2381-95. PubMed ID: 17125181
    [Abstract] [Full Text] [Related]

  • 26. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S, Miller AD, Keller M.
    Biochemistry; 2004 Oct 26; 43(42):13348-56. PubMed ID: 15491141
    [Abstract] [Full Text] [Related]

  • 27. Construction and transfection of PCR products expressing siRNAs or shRNAs in mammalian cells.
    Castanotto D, Rossi JJ.
    Methods Mol Biol; 2004 Oct 26; 252():509-14. PubMed ID: 15017076
    [Abstract] [Full Text] [Related]

  • 28. Recent progress in biomolecular engineering.
    Ryu DD, Nam DH.
    Biotechnol Prog; 2000 Oct 26; 16(1):2-16. PubMed ID: 10662483
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. siRNAs in drug discovery: target validation and beyond.
    Natt F.
    Curr Opin Mol Ther; 2007 Jun 26; 9(3):242-7. PubMed ID: 17608022
    [Abstract] [Full Text] [Related]

  • 31. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH, Quo CF, Wang MD.
    Prog Brain Res; 2006 Jun 26; 158():83-108. PubMed ID: 17027692
    [Abstract] [Full Text] [Related]

  • 32. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H, Tonge PJ.
    Acc Chem Res; 2008 Jan 26; 41(1):11-20. PubMed ID: 18193820
    [Abstract] [Full Text] [Related]

  • 33. High-content screening moves to the front of the line.
    Haney SA, LaPan P, Pan J, Zhang J.
    Drug Discov Today; 2006 Oct 26; 11(19-20):889-94. PubMed ID: 16997138
    [Abstract] [Full Text] [Related]

  • 34. Exploring the sounds of silence: RNAi-mediated gene silencing for target identification and validation.
    Chatterjee-Kishore M, Miller CP.
    Drug Discov Today; 2005 Nov 15; 10(22):1559-65. PubMed ID: 16257379
    [Abstract] [Full Text] [Related]

  • 35. Statistical analysis of systematic errors in high-throughput screening.
    Kevorkov D, Makarenkov V.
    J Biomol Screen; 2005 Sep 15; 10(6):557-67. PubMed ID: 16103415
    [Abstract] [Full Text] [Related]

  • 36. RNAi microarray analysis in cultured mammalian cells.
    Mousses S, Caplen NJ, Cornelison R, Weaver D, Basik M, Hautaniemi S, Elkahloun AG, Lotufo RA, Choudary A, Dougherty ER, Suh E, Kallioniemi O.
    Genome Res; 2003 Oct 15; 13(10):2341-7. PubMed ID: 14525932
    [Abstract] [Full Text] [Related]

  • 37. Statistical and graphical methods for quality control determination of high-throughput screening data.
    Gunter B, Brideau C, Pikounis B, Liaw A.
    J Biomol Screen; 2003 Dec 15; 8(6):624-33. PubMed ID: 14711388
    [Abstract] [Full Text] [Related]

  • 38. Fabrication of cell-based arrays using micropatterned alkanethiol monolayers for the parallel silencing of specific genes by small interfering RNA.
    Fujimoto H, Yoshizako S, Kato K, Iwata H.
    Bioconjug Chem; 2006 Dec 15; 17(6):1404-10. PubMed ID: 17105217
    [Abstract] [Full Text] [Related]

  • 39. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
    Sukuru SC, Jenkins JL, Beckwith RE, Scheiber J, Bender A, Mikhailov D, Davies JW, Glick M.
    J Biomol Screen; 2009 Jul 15; 14(6):690-9. PubMed ID: 19531667
    [Abstract] [Full Text] [Related]

  • 40. How will RNAi facilitate drug development?
    Bartz S, Jackson AL.
    Sci STKE; 2005 Aug 02; 2005(295):pe39. PubMed ID: 16077085
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.